Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
195 Avelumab internalization and lysosomal degradation by circulating immune cells in human is mediated by both Fc gamma Receptor (FcgR) and PD-L1 binding
Compose a Response to This Article
Other responses
No responses have been published for this article.